(3R,4R,5S)-4-Acetamido-3-(pentan-3-yloxy)-5-((4-(phenylsulfonyl)benzyl)amino)cyclohex-1-ene-1-carboxylic Acid

ID: ALA4291818

Chembl Id: CHEMBL4291818

PubChem CID: 145988935

Max Phase: Preclinical

Molecular Formula: C27H34N2O6S

Molecular Weight: 514.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(S(=O)(=O)c3ccccc3)cc2)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C27H34N2O6S/c1-4-21(5-2)35-25-16-20(27(31)32)15-24(26(25)29-18(3)30)28-17-19-11-13-23(14-12-19)36(33,34)22-9-7-6-8-10-22/h6-14,16,21,24-26,28H,4-5,15,17H2,1-3H3,(H,29,30)(H,31,32)/t24-,25+,26+/m0/s1

Standard InChI Key:  GKWMWVUUFNLURX-JIMJEQGWSA-N

Alternative Forms

  1. Parent:

    ALA4291818

    ---

Associated Targets(non-human)

Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.64Molecular Weight (Monoisotopic): 514.2138AlogP: 3.47#Rotatable Bonds: 11
Polar Surface Area: 121.80Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.89CX Basic pKa: 8.32CX LogP: 1.07CX LogD: 1.03
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.42Np Likeness Score: 0.03

References

1. Zhang J, Murugan NA, Tian Y, Bertagnin C, Fang Z, Kang D, Kong X, Jia H, Sun Z, Jia R, Gao P, Poongavanam V, Loregian A, Xu W, Ma X, Ding X, Huang B, Zhan P, Liu X..  (2018)  Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.,  61  (22): [PMID:30365885] [10.1021/acs.jmedchem.8b01065]

Source